“together we share support, united we manifest strength” sJ palm
APOPS FOUNDER SHERRIE PALM
Sherrie Palm is the Founder/CEO of Association for Pelvic Organ Prolapse Support (APOPS), a pelvic organ prolapse (POP) Key Opinion Leader, author of award winning book Pelvic Organ Prolapse: The Silent Epidemic, and an international advocate and public speaker on women's health empowerment and multiple aspects of pelvic organ prolapse quality of life impact. Sherrie’s points of focus are generating global POP awareness, developing guidance and support structures for women navigating POP, and bridge building within POP healthcare, research, academia, industry, corporate, and policy sectors, toward the evolution of POP directives.
Sherrie Palm's journey began in December 2007, with her diagnosis of pelvic organ prolapse. Upon returning home and researching POP, Sherrie discovered how common the condition is, that it had been medically documented for nearly 4000 years, and that stigma continued to shroud the condition in silence. In an effort to increase awareness of pelvic organ prolapse, Sherrie wrote the first edition of Pelvic Organ Prolapse: The Silent Epidemic, published in April 2009. Information on them 3rd edition is available here. While marketing the first edition, Sherrie recognized the most effective way to guide and support women with POP was to found a nonprofit, and in 2010, APOPS became a federally recognized 501(c)(3) nonprofit agency.
Contact Sherrie Palm regarding presenting at your event via APOPS landline at 262-642-4338 or via email @ email@example.com.
The most significant step we can take to improve quality of life for women with pelvic organ prolapse is educate them about the signs, symptoms, and treatment options of POP. Pelvic Organ Prolapse: The Silent Epidemic is a book to assist women navigating POP, to enable diagnostic clinicians to understand the reality vs the misconceptions of POP, and for specialists to share with their patients to bridge the gaps in understanding treatments. Understanding the condition empowers women to help themselves, and enables them to move forward with their lives effectively. APOPS provides additional tools to enable women to support each other on their journey via our multiple social media platforms (links at the in the footer at the bottom of the page).
It is equally important specialists continue to advance best practices to address patient need safely and effectively. Toward this need, Sherrie Palm contributed a chapter to The Innovation and Evolution of Medical Devices: Vaginal Mesh Kits, Edited by Abbas S. Shobeiri, M.D. Sherrie Palm’s contribution, chapter 6 Medical Device Innovation and Errors: The Patient Perspective, dissects the physical, emotional, social, sexual, fitness, and employment quality of life impact of pelvic organ prolapse to women’s lives. It additionally explores health care tunnel vision,
navigation of mesh complications, the POP workforce, regulatory evolution, technology, patient safety, and next steps. Additional information on this medical tome is available here.
Misconceptions abound in the field of pelvic organ prolapse. To advance POP understanding, we must clarify the reality of impact to quality of life to enable clinicians to recognize misconceptions. Diagnostic clinicians are currently poorly educated about pelvic organ prolapse. Despite childbirth and menopause being the leading causes of POP, women are currently not screened for the condition during routine pelvic exams.
It is imperative all sectors engaged in the POP arena bridge together to recognize, evaluate, and address pelvic organ prolapse. Industry develops both surgical and non-surgical treatments, and it is imperative they understand the needs of women navigating pelvic organ prolapse.
Policy is a key aspect of the evolution of POP awareness, diagnosis, treatment, and research. Representing the needs of women at legislative priority meetings is a pivotal aspect of generating much needed evolution in all aspects of pelvic organ prolapse diagnostics and treatment. Sherrie Palm sits on the Medical Device Epidemiology Network (MDEpiNET), a coalition of government, healthcare, industry, and nonprofits, is advancing efforts to address deficits in women’s pelvic healthcare.